Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.

AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.

Researchers have found 110 antiviral targets and several existing drugs that may hit them using gene-trap insertional mutagenesis and a computational framework…

In a recent effort to characterize new targets of obesity, a collaborative effort has suggested a new mechanism that regulates obesity in the mouse’s brain.

Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.

Quertle has introduced a platform to enable researchers to unearth relevant information from journal articles, patents and other documents.

A team at Stanford University School of Medicine has struck a liver cancer drug discovery deal with Andreessen Horowitz-backed twoXAR.

Medidata has teamed up with Shyft Analytics to use real-world evidence data to inform drug development strategies.

Sands Capital Ventures and Sequoia India have led precision oncology player Mitra Biotech to a $27.4 million Series B round.